Several media organisations have published headlines that alluded the ward boy who died of heart attack in Moradabad, had lost his life because of COVID-19 vaccine
With apprehensions surrounding Chinese vaccines swelling, India has taken a lead in helping the world to combat coronavirus with its indigenously developed COVID-19 vaccines
Earlier, Covaxin was approved for children above 12, while SII's Covishield was approved for persons above 18. The new order states that Covaxin will also be administered only to persons above 18.